undamentalytics Newsletter

Cormedix Inc. balance sheet

At the end of fiscal 2025, Cormedix Inc. had total assets of $826m, total liabilities of $421m and shareholders' equity of $405m. It held $145m in cash against $144,626 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cormedix Inc.: balance sheet, annual
Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents12412810181642534341145257
Receivables0000000————52171161
Inventory0000010000—83039
Total current assets1353722131929486660115367481
Goodwill————————————3030
Total assets1353722131929496962119826904
Accounts payable111222311222810
Deferred revenue (current)—0000000——————
Total current liabilities1213468645634174187
Long-term debt—————06—————0—
Total debt0000006—000000
Total liabilities17134614656734421443
Shareholders' equity−0−443418752444635585405461
Shares outstanding——————22m26m34m38m43m64m79m78m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ARQT vs CRMDCRMD vs KRYSARDX vs CRMD

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Cormedix Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cormedix Inc.